PERSISTENT CORNEAL EPITHELIAL DEFECT
Clinical trials for PERSISTENT CORNEAL EPITHELIAL DEFECT explained in plain language.
Never miss a new study
Get alerted when new PERSISTENT CORNEAL EPITHELIAL DEFECT trials appear
Sign up with your email to follow new studies for PERSISTENT CORNEAL EPITHELIAL DEFECT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Eye drop breakthrough: nerve growth factor heals corneal wounds in phase 3 trial
⭐️ CURE ⭐️ Recruiting nowThis study tests an eye drop containing a human nerve growth factor to help heal persistent corneal defects (wounds on the eye's surface that won't close). About 150 adults with such wounds will receive either the active drop or a placebo. The goal is to see if the drop can fully…
Matched conditions: PERSISTENT CORNEAL EPITHELIAL DEFECT
Phase: PHASE3 • Sponsor: Dompé Farmaceutici S.p.A • Aim: ⭐️ CURE ⭐️
Last updated Jul 18, 2026 00:00 UTC
-
Insulin eye drops vs. surgery: a new hope for stubborn corneal wounds?
Disease control Recruiting nowThis study tests whether insulin eye drops can heal persistent corneal defects as well as a surgical amniotic membrane graft. 214 adults with corneal sores that haven't healed after two weeks of standard treatment will receive either insulin drops every six hours or a graft. Rese…
Matched conditions: PERSISTENT CORNEAL EPITHELIAL DEFECT
Phase: PHASE4 • Sponsor: Al-Shifa Trust Eye Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Stem cell eye drops aim to heal stubborn corneal wounds
Disease control Recruiting nowThis study tests whether eye drops made from stem cell secretions can help heal persistent corneal defects that haven't improved with standard treatments. About 24 adults with chronic corneal damage will receive either the active drops or a placebo for 8 weeks. The main goal is t…
Matched conditions: PERSISTENT CORNEAL EPITHELIAL DEFECT
Phase: PHASE2 • Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC